ITL Group Lands Contract with Chinese Diagnostics Company


Reading time ( words)

ITL Group, a Gooch & Housego company, has secured a major R&D contract with a global Chinese diagnostics company specializing in in-vitro diagnostics (IVD).

The company intends to fully utilize ITL’s experienced R&D team for the complete development of a microfluidic cartridge and molecular point-of-care diagnostic system for the detection of respiratory infections in children.

All R&D for the project will be carried out at ITL’s UK headquarters based in Ashford, Kent. The team will carry out feasibility studies, extensive market research and concept design in order to identify the best route forward.

One of the key factors in securing the contract was ITL’s ISO 13485 accredited manufacturing facility in Shanghai. With long-term plans to manufacture the product in China, it was hugely beneficial to find a contract partner with a full understanding of the Chinese language, regulatory landscape, business, and cultural environment, and the importance of building relationships within the country.

“This is a really exciting time for us. We’ve seen phenomenal growth over the last few years, with an outstanding 20% growth in first half of 2019. This contract is one of many that we have secured this year and it’s truly a credit to our employees and our 42 years in the MedTech industry,” said Tom Cole, managing director of ITL.

Share

Print


Suggested Items

Will Moisture Management Expand to the U.S. Market?

02/19/2020 | Nolan Johnson, I-Connect007
Rich Heimsch, Super Dry director, chats with Nolan Johnson about the growing demand for moisture management in North America versus its earlier adoption in Europe, and how moisture management fits into Industry 4.0 and the smart factory.

Phil Carmichael: IPC Asia Continues Solid Growth

02/07/2020 | Barry Matties, I-Connect007
Phil Carmichael, IPC president of Asia Pacific, talks with Barry Matties at the HKPCA show during the first week of December 2019 about the continued growth and increased engagement by Asian member companies with IPC, with over 320 members in standards committees now working on the development of the next-generation standards.

The Digital Medical Revolution

12/02/2019 | Nolan Johnson, I-Connect007
Zulki Khan, founder and CEO of NexLogic Technologies Inc., offers his unique perspective on manufacturing trends as a PCB turnkey solutions provider based in Silicon Valley. He discusses additional requirements that are now necessary to compete in different industry sectors, most notably medical, which he says is set for a “digital revolution.”



Copyright © 2020 I-Connect007. All rights reserved.